Rapid and Continuing Improvements in Nasal Symptoms with Dupilumab in Patients with Severe CRSwNP.

Claus Bachert Asif Hameed Khan Claire Hopkins Michael S BlaissZachary M SolerScott NashShahid SiddiquiAmy PraestgaardYamo DenizPaul J RoweJuby A Jacob-Nara

Published in: Journal of asthma and allergy (2022)

Dupilumab provided rapid, continuing, and clinically relevant improvements over time in NPS and NC in most patients with severe CRSwNP in the SINUS studies.

Keyphrases

atopic dermatitis
early onset
medical education
loop mediated isothermal amplification
drug induced